Design of PAP-1, a selective small molecule Kv1. 3 blocker, for the suppression of effector memory T cells in autoimmune diseases
…, A Sankaranarayanan, P Azam, K Schmidt-Lassen…
Index: Schmitz, Alexander; Sankaranarayanan, Ananthakrishnan; Azam, Philippe; Schmidt-Lassen, Kristina; Homerick, Daniel; Haensel, Wolfram; Wulff, Heike Molecular Pharmacology, 2005 , vol. 68, # 5 p. 1254 - 1270
Full Text: HTML
Citation Number: 138
Abstract
Abstract The lymphocyte K+ channel Kv1. 3 constitutes an attractive pharmacological target for the selective suppression of terminally differentiated effector memory T (T EM) cells in T cell-mediated autoimmune diseases, such as multiple sclerosis and type 1 diabetes. Unfortunately, none of the existing small-molecule Kv1. 3 blockers is selective, and many of them, such as correolide, 4-phenyl-4-[3-(methoxyphenyl)-3-oxo-2-azapropyl] ...
Related Articles:
[Li, Yan; Li, Guangtao; Wang, Xinyan; Lin, Changxu; Zhang, Yihe; Ju, Yong Chemistry - A European Journal, 2008 , vol. 14, # 33 p. 10331 - 10339]
Synthesis of N-aryloxyalkylanabasine derivatives
[Slyn'Ko; Tatarova; Shakirov; Shul'Ts Chemistry of Natural Compounds, 2013 , vol. 49, # 2 p. 294 - 301 Khim. Prir. Soedin., 2013 , # 2 p. 250 - 256,7]